JP2013508289A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013508289A5 JP2013508289A5 JP2012534359A JP2012534359A JP2013508289A5 JP 2013508289 A5 JP2013508289 A5 JP 2013508289A5 JP 2012534359 A JP2012534359 A JP 2012534359A JP 2012534359 A JP2012534359 A JP 2012534359A JP 2013508289 A5 JP2013508289 A5 JP 2013508289A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- nitrite
- composition according
- plasma concentration
- maintained
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US25148309P | 2009-10-14 | 2009-10-14 | |
| US61/251,483 | 2009-10-14 | ||
| PCT/US2010/052683 WO2011047161A1 (en) | 2009-10-14 | 2010-10-14 | Pharmaceutical formulations of nitrite and uses thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015113882A Division JP6125567B2 (ja) | 2009-10-14 | 2015-06-04 | ニトライトの医薬製剤及びそれらの使用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013508289A JP2013508289A (ja) | 2013-03-07 |
| JP2013508289A5 true JP2013508289A5 (enExample) | 2013-10-31 |
| JP5758904B2 JP5758904B2 (ja) | 2015-08-05 |
Family
ID=43855036
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012534359A Active JP5758904B2 (ja) | 2009-10-14 | 2010-10-14 | ニトライトの医薬製剤及びそれらの使用 |
| JP2015113882A Active JP6125567B2 (ja) | 2009-10-14 | 2015-06-04 | ニトライトの医薬製剤及びそれらの使用 |
| JP2017074888A Pending JP2017141275A (ja) | 2009-10-14 | 2017-04-05 | ニトライトの医薬製剤及びそれらの使用 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015113882A Active JP6125567B2 (ja) | 2009-10-14 | 2015-06-04 | ニトライトの医薬製剤及びそれらの使用 |
| JP2017074888A Pending JP2017141275A (ja) | 2009-10-14 | 2017-04-05 | ニトライトの医薬製剤及びそれらの使用 |
Country Status (10)
| Country | Link |
|---|---|
| US (4) | US10463689B2 (enExample) |
| EP (1) | EP2488035B1 (enExample) |
| JP (3) | JP5758904B2 (enExample) |
| CN (2) | CN107260756A (enExample) |
| AU (1) | AU2010306755B2 (enExample) |
| CA (1) | CA2777066C (enExample) |
| ES (1) | ES2633618T3 (enExample) |
| IL (1) | IL219155A0 (enExample) |
| IN (1) | IN2012DN03428A (enExample) |
| WO (1) | WO2011047161A1 (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9649334B2 (en) | 2007-11-15 | 2017-05-16 | The Uab Research Foundation | Use of nitrite salts in chronic ischemia |
| US20120237617A1 (en) | 2009-06-18 | 2012-09-20 | Theravasc Inc. | Use of nitrite salts in treating tissue damage |
| WO2011047161A1 (en) * | 2009-10-14 | 2011-04-21 | TheraVasc, LLC | Pharmaceutical formulations of nitrite and uses thereof |
| BR112014003414B1 (pt) | 2011-08-17 | 2021-09-21 | Board Of Regents, The University Of Texas System | Composição e sistema de entrega oral para aumento de níveis fisiológicos e terapêuticos de óxido nítrico |
| US8627204B2 (en) * | 2011-10-18 | 2014-01-07 | Microsoft Corporation | Custom optimization of web pages |
| JP2016509030A (ja) | 2013-02-20 | 2016-03-24 | セラバスク インコーポレーテッド | ニトライトの医薬製剤及びそれらの使用 |
| EP2994165A4 (en) * | 2013-05-10 | 2017-01-04 | Nitromega Corp. | Nutritional or dietary supplements containing fatty acids and nitrite |
| GB201309092D0 (en) * | 2013-05-20 | 2013-07-03 | Edixomed Ltd | Transdermal delivery system |
| US20170349438A1 (en) | 2016-06-06 | 2017-12-07 | Theravasc Inc. | Pharmaceutical formulations of nitrite and uses thereof |
| JP2020508308A (ja) * | 2017-02-20 | 2020-03-19 | ボード オブ スーパーバイザーズ オブ ルイジアナ ステート ユニバーシティ アンド アグリカルチュアル アンド メカニカル カレッジ | 心房細動の治療及び予防における硫化水素及び／又は亜硝酸塩 |
| US11850271B1 (en) * | 2023-05-16 | 2023-12-26 | King Faisal University | Topical skin cream |
Family Cites Families (45)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2914446A (en) * | 1958-06-26 | 1959-11-24 | Upjohn Co | Nitrite stabilized ascorbic acid-cyanocobalamin compositions |
| US4650484A (en) | 1983-02-03 | 1987-03-17 | Alza Corporation | Method for treating ischemic conditions |
| IE64726B1 (en) | 1987-11-20 | 1995-08-23 | Elan Corp Plc | Pharmaceutical formulations for preventing drug tolerance |
| US5122384A (en) | 1989-05-05 | 1992-06-16 | Kv Pharmaceutical Company | Oral once-per-day organic nitrate formulation which does not induce tolerance |
| US5278192A (en) * | 1992-07-02 | 1994-01-11 | The Research Foundation Of State University Of New York | Method of vasodilator therapy for treating a patient with a condition |
| US6709681B2 (en) | 1995-02-17 | 2004-03-23 | Aberdeen University | Acidified nitrite as an antimicrobial agent |
| US20110196039A9 (en) * | 1994-10-05 | 2011-08-11 | Kaesemeyer Wayne H | Controlled release arginine formulations |
| US5648101A (en) | 1994-11-14 | 1997-07-15 | Tawashi; Rashad | Drug delivery of nitric oxide |
| US5770645A (en) | 1996-08-02 | 1998-06-23 | Duke University Medical Center | Polymers for delivering nitric oxide in vivo |
| US5994444A (en) * | 1997-10-16 | 1999-11-30 | Medtronic, Inc. | Polymeric material that releases nitric oxide |
| US7371415B1 (en) | 1998-04-03 | 2008-05-13 | The Daily Wellness Company | Method and composition for improving sexual fitness |
| US7015876B1 (en) * | 1998-06-03 | 2006-03-21 | Lear Corporation | Heads-up display with improved contrast |
| WO2000003725A1 (en) | 1998-07-14 | 2000-01-27 | Paracelsian, Inc. | Method for identifying and confirming consistent bio-functionality of natural compositions |
| JP2002535353A (ja) | 1999-01-29 | 2002-10-22 | ロザン ファルマ ゲゼルシャフトミットベシュレンクテルハフツンク | 医薬品組成物 |
| GB9905425D0 (en) | 1999-03-09 | 1999-05-05 | Queen Mary & Westfield College | Pharmaceutical composition |
| US6314956B1 (en) | 1999-09-08 | 2001-11-13 | Duke University | Pulmonary delivery of NO group-containing compound in gas form to treat respiratory, cardiac and blood disorders |
| GB0119011D0 (en) | 2001-08-03 | 2001-09-26 | Univ Aberdeen | Treatment of nail infections |
| EP1492509A1 (en) | 2001-12-18 | 2005-01-05 | ALZA Corporation | Dosage form providing time-varying patterns of drug delivery |
| EP1336602A1 (en) | 2002-02-13 | 2003-08-20 | Giovanni Scaramuzzino | Nitrate prodrugs able to release nitric oxide in a controlled and selective way and their use for prevention and treatment of inflammatory, ischemic and proliferative diseases |
| CN100430399C (zh) * | 2002-03-20 | 2008-11-05 | 昆士兰大学 | 包含一氧化氮供体和阿片样物质止痛剂的组合物和方法 |
| CA2379211A1 (fr) | 2002-03-28 | 2003-09-28 | Institut De Cardiologie De Montreal | Utilisation du bleu de methylene pour renverser la reaction hemodynamique exageree induite par la combinaison d'un derive nitre et du sildenafil ou d'une molecule de meme classe (inhibiteur de la phosphodiesterase) |
| JP5564157B2 (ja) * | 2003-07-09 | 2014-07-30 | ザ ガバメント オブ ザ ユナイテッド ステイツ オブ アメリカ アズ リプレゼンテッド バイ ザ セクレタリー オブ ザ デパートメント オブ ヘルス アンド ヒューマン サービシーズ | 心臓血管状態の処置のための亜硝酸塩の使用方法 |
| WO2005018561A2 (en) | 2003-08-20 | 2005-03-03 | Nitromed, Inc. | Nitrosated and nitrosylated cardiovascular compounds, compositions and methods of use |
| US20050113409A1 (en) | 2003-09-03 | 2005-05-26 | Pharmacia Corporation | Method for the prevention or treatment of pain, inflammation and inflammation-related disorders with a Cox-2 selective inhibitor in combination with a nitric oxide-donating agent and compositions therewith |
| US7362274B1 (en) | 2004-07-09 | 2008-04-22 | Huan-Cheng Lien | Coupled feed-in butterfly shaped left/right hand circularly polarized microstrip antenna |
| US20060083824A1 (en) | 2004-10-20 | 2006-04-20 | Pbm Products Llc | Nutritional supplements for glucose intolerant individuals |
| JP5175107B2 (ja) * | 2005-02-11 | 2013-04-03 | ノーラブズ エービー | 酸化窒素による神経障害の治療デバイス、方法および使用 |
| JP2008542300A (ja) | 2005-05-24 | 2008-11-27 | ウェルルゲン インコーポレーテッド | 炎症と関連した状態を予防及び治療するための組成物及び方法 |
| BRPI0621321A2 (pt) * | 2006-02-10 | 2011-12-06 | Mannatech Inc | formulações de suplemento dietético de multivitamìnico e multimineral natural para melhor absorção e utilização biológica |
| GB0607402D0 (en) | 2006-04-12 | 2006-05-24 | Barts & London Nhs Trust | Therapeutic composition and use |
| US8333997B2 (en) | 2006-06-21 | 2012-12-18 | Albert Einstein College Of Medicine Of Yeshiva University | Compositions for sustained release of nitric oxide, methods of preparing same and uses thereof |
| AU2008219834C1 (en) | 2007-02-26 | 2015-11-12 | Heartbeet Ltd. | New use of nitrites and nitrates and compositions containing these |
| ES2618655T3 (es) | 2007-02-26 | 2017-06-21 | Heartbeet Ltd. | Composición que mejora el rendimiento y uso de la misma |
| WO2008153762A2 (en) | 2007-05-25 | 2008-12-18 | N30 Pharmaceuticals, Llc | S-nitrosothiol formulations and storage systems |
| JP5592790B2 (ja) * | 2007-08-06 | 2014-09-17 | トリニティ ラボラトリーズ インコーポレイテッド | 慢性疼痛およびニューロパシーに関連する疼痛を治療する医薬組成物 |
| US9649334B2 (en) | 2007-11-15 | 2017-05-16 | The Uab Research Foundation | Use of nitrite salts in chronic ischemia |
| US20090196930A1 (en) | 2007-12-27 | 2009-08-06 | Aires Pharmaceuticals, Inc. | Aerosolized nitrite and nitric oxide -donating compounds and uses thereof |
| WO2010036236A1 (en) | 2008-09-23 | 2010-04-01 | Baker Hughes Incorporated | Anchor assembly |
| US8568793B2 (en) * | 2009-02-11 | 2013-10-29 | Hope Medical Enterprises, Inc. | Sodium nitrite-containing pharmaceutical compositions |
| US20120237617A1 (en) | 2009-06-18 | 2012-09-20 | Theravasc Inc. | Use of nitrite salts in treating tissue damage |
| WO2011047161A1 (en) | 2009-10-14 | 2011-04-21 | TheraVasc, LLC | Pharmaceutical formulations of nitrite and uses thereof |
| US20130209584A1 (en) | 2009-10-14 | 2013-08-15 | Theravasc Inc. | Pharmaceutical formulations of nitrite and uses thereof |
| WO2012135623A1 (en) | 2011-03-31 | 2012-10-04 | Theravasc Inc. | Use of nitrites for the treatment of cerebral amyloid angiopathy, age associated dementia, and cognitive decline |
| WO2012142413A2 (en) | 2011-04-14 | 2012-10-18 | Theravasc Inc. | Nitrite compositions and uses thereof |
| US9294956B2 (en) | 2011-12-29 | 2016-03-22 | Qualcomm Incorporated | Application-server-assisted preemptive multicast bearer establishment for real-time low-latency applications |
-
2010
- 2010-10-14 WO PCT/US2010/052683 patent/WO2011047161A1/en not_active Ceased
- 2010-10-14 JP JP2012534359A patent/JP5758904B2/ja active Active
- 2010-10-14 IN IN3428DEN2012 patent/IN2012DN03428A/en unknown
- 2010-10-14 CA CA2777066A patent/CA2777066C/en active Active
- 2010-10-14 CN CN201710462544.3A patent/CN107260756A/zh active Pending
- 2010-10-14 US US12/904,791 patent/US10463689B2/en active Active
- 2010-10-14 CN CN2010800568984A patent/CN102686111A/zh active Pending
- 2010-10-14 ES ES10824097.9T patent/ES2633618T3/es active Active
- 2010-10-14 AU AU2010306755A patent/AU2010306755B2/en not_active Ceased
- 2010-10-14 EP EP10824097.9A patent/EP2488035B1/en active Active
-
2012
- 2012-04-15 IL IL219155A patent/IL219155A0/en unknown
-
2015
- 2015-06-04 JP JP2015113882A patent/JP6125567B2/ja active Active
- 2015-09-08 US US14/847,966 patent/US10307441B2/en active Active
-
2017
- 2017-04-05 JP JP2017074888A patent/JP2017141275A/ja active Pending
-
2019
- 2019-10-11 US US16/599,710 patent/US20200085861A1/en not_active Abandoned
-
2020
- 2020-06-11 US US16/898,460 patent/US20200297756A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013508289A5 (enExample) | ||
| RU2018109222A (ru) | Пероральные составы, содержащие аналоги цитидина, и способы их использования | |
| HRP20250480T1 (hr) | Kombinacija dasatiniba i adagrasiba za primjenu u liječenju nesitnostaničnog raka pluća | |
| WO2013101897A3 (en) | Improved compositions and methods for delivery of omeprazole plus acetylsalicylic acid | |
| JP2012502015A5 (enExample) | ||
| JP2012502047A5 (enExample) | ||
| HK1221646A1 (zh) | 高剂量普利多匹定用於治疗亨廷顿舞蹈症的用途 | |
| JP2012180381A5 (enExample) | ||
| WO2009110005A3 (en) | Modified release pharmaceutical compositions comprising mycophenolate and processes thereof | |
| NZ625592A (en) | Compositions and methods for the treatment of hepatic diseases and disorders | |
| JP2012193216A5 (enExample) | ||
| JP2015038135A5 (enExample) | ||
| MX2011007779A (es) | Formulaciones galenicas de compuestos organicos. | |
| WO2011118976A3 (en) | Pharmaceutical composition for the prevention or the treatment of non-alcoholic fatty liver disease and the method for prevention or treatment of non-alcoholic fatty liver disease using the same | |
| RU2011152105A (ru) | Составы таблеток 3-цианохинолина и их применение | |
| FI4212152T3 (fi) | Sakubitriili-valsartaaniannostusohjelma kroonisen systolisen sydämen vajaatoiminnan hoitoon | |
| NZ587202A (en) | Methods for measuring a patient response upon administration of a drug and compositions thereof | |
| WO2009034431A3 (en) | Controlled-release dosage forms for varenicline | |
| JP2014503593A5 (enExample) | ||
| JP2009513713A5 (enExample) | ||
| WO2012020301A3 (en) | Oral controlled release pharmaceutical compositions of blonanserin | |
| WO2007145863A3 (en) | Sustained release formulation of naltrexone | |
| JP2016512247A5 (enExample) | ||
| RU2018146504A (ru) | Лечение внутрипеченочных холестатических заболеваний | |
| JP2016505050A5 (enExample) |